Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GLAXF) Net Margin (2016 - 2025)

Historic Net Margin for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to 23.55%.

  • Gsk's Net Margin rose 242800.0% to 23.55% in Q3 2025 from the same period last year, while for Dec 2025 it was 21.12%, marking a year-over-year increase of 98000.0%. This contributed to the annual value of 8.21% for FY2024, which is 80400.0% down from last year.
  • According to the latest figures from Q3 2025, Gsk's Net Margin is 23.55%, which was up 242800.0% from 18.07% recorded in Q2 2025.
  • In the past 5 years, Gsk's Net Margin ranged from a high of 138.22% in Q3 2022 and a low of 0.72% during Q3 2024
  • Moreover, its 5-year median value for Net Margin was 18.7% (2022), whereas its average is 24.06%.
  • Per our database at Business Quant, Gsk's Net Margin skyrocketed by 1205900bps in 2022 and then tumbled by -1202500bps in 2023.
  • Over the past 5 years, Gsk's Net Margin (Quarter) stood at 10.59% in 2021, then soared by 77bps to 18.7% in 2022, then grew by 18bps to 22.04% in 2023, then plummeted by -34bps to 14.55% in 2024, then surged by 62bps to 23.55% in 2025.
  • Its Net Margin was 23.55% in Q3 2025, compared to 18.07% in Q2 2025 and 21.61% in Q1 2025.